The development and validation of a high-throughput LC-MS/MS method for the analysis of endogenous β-hydroxy-β-methylbutyrate in human plasma.

Subramanian Ramachandran, Stefan Ehling, Sathyavageeswaran Shreeram, Todime M Reddy
Author Information
  1. Subramanian Ramachandran: Syngene International Limited, Bangalore, India.
  2. Stefan Ehling: Abbott Laboratories, Columbus, OH, USA.
  3. Sathyavageeswaran Shreeram: Abbott Laboratories, Columbus, OH, USA.
  4. Todime M Reddy: Abbott Laboratories, Columbus, OH, USA.

Abstract

A high-throughput, sensitive, and rugged liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the rapid quantitation of β-hydroxy-β-methylbutyrate (HMB) in human plasma has been developed and validated for routine use. The method uses 100 μL of plasma sample and employs protein precipitation with 0.1% formic acid in methanol for the extraction of HMB from plasma. Sample extracts were analyzed using LC-MS/MS technique under negative mode electrospray ionization conditions. A C-labeled stable isotope internal standard was used to achieve accurate quantitation. Multiday validation was conducted for precision, accuracy, linearity, selectivity, matrix effect, dilution integrity (2×), extraction recovery, freeze-thaw sample stability (three cycles), benchtop sample stability (6 h and 50 min), autosampler stability (27 h) and frozen storage sample stability (146 days). Linearity was demonstrated between 10 and 500 ng/mL. Inter-day accuracies and coefficients of variation (CV) were 91.2-98.1 and 3.7-7.8%, respectively. The validated method was proven to be rugged for routine use to quantify endogenous levels of HMB in human plasma obtained from healthy volunteers.

Keywords

MeSH Term

Chromatography, Liquid
Humans
Reference Standards
Tandem Mass Spectrometry
Valerates

Chemicals

Valerates
beta-hydroxyisovaleric acid

Word Cloud

Similar Articles

Cited By